uniQure N.V. (QURE) Rises 8.15% on June 21

Equities Staff  |

uniQure N.V. (NASDAQ: QURE) has gained $1.15 (8.15%) and is currently sitting at $15.15, as of 12:06:43 est on June 21.

315,420 shares have exchanged hands.

The Company has risen 5.38% over the last 5 days and shares have risen 2.84% over the last 30 days.

uniQure N.V. is set to release earnings on 2022-07-25.

For technical charts, analysis, and more on uniQure N.V. visit the company profile.

About uniQure N.V.

uniQure is delivering on the promise of gene therapy - single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary gene therapies to treat patients with hemophilia B, Huntington's disease, Fabry disease, spinocerebellar ataxia Type 3 and other diseases.

To get more information on uniQure N.V. and to follow the company's latest updates, you can visit the company's profile page here: uniQure N.V.'s Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Trending Articles

Investors Must Understand 5G Wireless Growth Wave: Jeff Kagan
'Goldilocks' Stocks Will Define This Decade
What You Need To Know About Bear Markets
Is Your iPhone Already Obsolete?

Market Movers

Sponsored Financial Content